18 employees
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
2018
$31M
from 3 investors over 3 rounds
Lassen Therapeutics raised $31M on June 17, 2020
Investors: Longwood Fund, Alta Partners and Frazier Healthcare Partners